Patent details

Basic Information

Publication number:

EP2289545

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP101785954

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Supplemented OMV vaccine against meningococcus

French Title of Invention:

Vaccin OMV contre le méningocoque

German Title of Invention:

Ergänzter Außenmembranvesikel-Impfstoff gegen Meningokokken

SPC Number:

Dates

Filing date:

17/01/2001

Grant date:

08/06/2016

EP Publication Date:

08/06/2016

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

02/03/2011

EP B1 Publication Date:

08/06/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

17/01/2018

Expiration date:

17/01/2021

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

17/01/2001

 

 

Name:

GlaxoSmithKline Biologicals SA

Address:

Rue de l'Institut 89, 1330 Rixensart, Belgium (BE)

Agent

Name:

KIRKPATRICK SA / NV

From:

08/08/2016

Address:

AVENUE WOLFERS 32, 1310, LA HULPE, Belgium (BE)

To:

Inventor

1

Name:

Giuliani Marzia

Address:

Italy (IT)

2

Name:

Rappuoli Rino

Address:

Italy (IT)

3

Name:

Pizza Mariagrazia

Address:

Italy (IT)

Priority

1

Priority Number:

0001067

Priority Date:

17/01/2000

Priority Country:

United Kingdom (GB)

2

Priority Number:

0005699

Priority Date:

09/03/2000

Priority Country:

United Kingdom (GB)

Classification

Main IPC Class:

A61K 39/00;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

06/04/2022

Last Annual Fee Paid Number:

17

Last Annual Fee Paid Amount:

246 Euro

Payer:

MDC (HENKEL PATENT)

Filing date	Document type	Number of pages
31/05/2018	Outgoing Correspondence	1